Last reviewed · How we verify

NCT04456881

Arthroscopic Clinical Study of Double Bundle Anatomical Reconstruction of Medial Patellofemoral Ligament

Status unknown NA Last updated 18 April 2023
What this trial tests

NA trial testing Patients with patellar dislocation undergo patellar femoral medial reconstruction in Recurrent Patellar Dislocation in 30 participants. Status unknown.

Timeline
1 January 2020
Primary endpoint
1 February 2024
1 May 2024

Quick facts

Lead sponsorPeking University Third Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment30
Start date1 January 2020
Primary completion1 February 2024
Estimated completion1 May 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking University Third Hospital

Who can join

Adults 17 to 60, any sex, with Recurrent Patellar Dislocation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: To study the clinical effect of double-beam anatomical reconstruction of medial patellofemoral ligament under arthroscopy. Methods: Double-beam anatomical reconstruction of medial patellofemoral ligament was performed under arthroscopy in patients admitted to our hospital for treatment of recurrent patellar dislocation. Carry out preoperative and postoperative evaluations, and conduct preoperative and postoperative comparative studies to clarify the clinical effect of the procedure. Expected results: Arthroscopic double-beam anatomical reconstruction of the medial patellofemoral ligament can effectively restore the stability of the patella and the motor function of the knee joint. Expected conclusion: Arthroscopic double-beam anatomical reconstruction of the medial patellofemoral ligament is an effective minimally invasive technique. Keywords: knee joint; medial patellofemoral ligament; double-beam anatomical reconstruction; arthroscopy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Peking University Third Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04456881.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing